Annette Mattsson
General Counsel bij CAMURUS AB
Vermogen: 142 578 $ op 31-03-2024
Profiel
Annette Mattsson is currently working as Vice President-Regulatory Affairs at Camurus AB since 2019.
Prior to this, she worked as Director-European RA at AstraZeneca AB.
Ms. Mattsson completed her undergraduate degree from the University of Uppsala and the University of Lund.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAMURUS AB
0.01% | 15-12-2023 | 3 004 ( 0.01% ) | 142 578 $ | 31-03-2024 |
Actieve functies van Annette Mattsson
| Bedrijven | Functie | Begin |
|---|---|---|
| CAMURUS AB | General Counsel | 01-01-2019 |
Eerdere bekende functies van Annette Mattsson
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Opleiding van Annette Mattsson
| University of Uppsala | Undergraduate Degree |
| University of Lund | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
